首页> 外文期刊>Journal of neurosurgery. >Magnetic resonance imaging dynamics of contrast medium uptake in vestibular schwannomas.
【24h】

Magnetic resonance imaging dynamics of contrast medium uptake in vestibular schwannomas.

机译:前庭神经鞘瘤中造影剂摄取的磁共振成像动力学。

获取原文
获取原文并翻译 | 示例
           

摘要

Object Efficacy of radiosurgery in vestibular schwannoma (VS) is usually documented by changes of tumor size and by loss of contrast enhancement in MR imaging within the central portion of the lesion. Until now, however, correlation between contrast enhancement and timing of image acquisition in nontreated VS has not been analyzed systematically. The authors undertook this study to investigate changes in contrast enhancement with respect to latency of image acquisition after contrast agent administration. Methods The dynamics of contrast medium uptake were evaluated with T1-weighted VIBE MR imaging sequences performed immediately and 1.5, 3.5, 4.5, 9.5, and 11.5 minutes after administration of single dose of Gd in 21 patients with nontreated medium- to large-sized VSs. Signal-to-noise (SNR) and contrast-to-noise ratio (CNR) of tumors were evaluated, and volumes of central nonenhancing areas (NEAs) were determined. Results The interior appearance of the tumors changed considerably over time. The NEA significantly diminished in size (p < 0.0001, Friedman test) and almost completely disappeared in all but 2 patients. Compared to images at 1.5 minutes, NEA volumes decreased to a median of 36% at 3.5 minutes and 34% at 4.5 minutes, showing smaller changes after that-9% at 9.5 minutes and 3% at 11.5 minutes. Tumor SNR and CNR increased over time. The maximum change in the median values for SNR and CNR were a 72% increase and 117% increase, respectively; both occurred at 1.5 minutes after Gd administration. Conclusions Contrast enhancement in VS MR imaging varies according to the duration of the delay between contrast agent administration and image acquisition. Postradiotherapy changes in contrast enhancement of VS can therefore not be attributed only to effective radiotherapy. So-called "loss of central contrast enhancement" may be falsely detected because of timing. A standardized protocol with defined timing of image acquisition may increase comparability of contrast uptake in VS.
机译:通常通过肿瘤大小的变化和病变中心部分MR成像对比度增强的丧失来证明前庭神经鞘瘤(VS)放射外科手术的目标疗效。然而,到目前为止,尚未系统分析在未处理的VS中对比度增强和图像获取时间之间的相关性。作者进行了这项研究,以调查对比增强剂在使用造影剂后相对于图像获取延迟的变化。方法采用21例未经治疗的大中型VS患者,立即和在单剂量Gd给药后1.5、3.5、4.5、9.5和11.5分钟执行T1加权VIBE MR成像序列评估造影剂摄取的动力学。 。评价了肿瘤的信噪比(SNR)和对比噪声比(CNR),并确定了中央非增强区域(NEA)的体积。结果肿瘤的外观随时间变化很大。 NEA的大小显着缩小(p <0.0001,Friedman检验),除2例患者外,其余几乎完全消失。与1.5分钟时的图像相比,NEA量在3.5分钟时下降到中位数的36%,在4.5分钟时下降到34%,在9.5分钟时下降9%,在11.5分钟时下降3%,显示出较小的变化。肿瘤SNR和CNR随时间增加。 SNR和CNR的中值的最大变化分别增加了72%和117%。两者均在给予Gd后1.5分钟发生。结论VS MR成像的对比度增强取决于造影剂给药和图像采集之间的延迟时间。因此,放疗后VS对比增强的变化不能仅仅归因于有效的放疗。由于定时,可能会错误地检测到所谓的“中央对比度增强损失”。具有定义的图像采集时间的标准化协议可能会增加VS中对比度摄取的可比性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号